Access to kidney care is limited in resource poor nations. Approximately 80% of the world’s Renal Replacement Therapy (RRT) patients live in Europe, Japan or North America. By contrast, less than 10% of Indian End Stage Kidney Disease (ESKD) patients receive RRT, while up to 70% of those starting dialysis die or stop treatment, due to cost, within the first 3 months.